Metadvice Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$325K
- Investors
-
4
Metadvice General Information
Description
Developer of a clinical decision intelligence platform designed to accelerate personalized healthcare. The company's platform combines the recent clinical guidelines, augmented with insights from artificial intelligence-based analyses of past decisions, to assess diagnostics and suggest therapies or treatments, enabling medical professionals to improve the quality, consistency, and personalization of clinical decision-making.
Contact Information
Website
www.metadvice.comCorporate Office
- 45 Pall Mall, (C/O New Medicine Partners)
- London SW1Y 5JG
- England, United Kingdom
Corporate Office
- 45 Pall Mall, (C/O New Medicine Partners)
- London SW1Y 5JG
- England, United Kingdom
Metadvice Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 01-Feb-2023 | $325K | Completed | Generating Revenue | ||
| 5. Grant | 01-Nov-2021 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 30-Sep-2020 | Completed | Startup | |||
| 3. Grant | 01-Sep-2020 | Completed | Startup | |||
| 2. Seed Round | 10-Mar-2020 | $647K | $647K | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Metadvice Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Metadvice Patents
Metadvice Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260137353-A1 | Method to determine insulin resistance from continuous glucose monitoring (cgm) for pre-diabetic conditions | Pending | 15-Nov-2024 |
Metadvice Signals
Metadvice Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| FutureMED VENTURES | Venture Capital | Minority | ||
| King's20 Accelerator | Accelerator/Incubator | |||
| Innovate UK | Government | |||
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator |
Metadvice FAQs
-
When was Metadvice founded?
Metadvice was founded in 2019.
-
Where is Metadvice headquartered?
Metadvice is headquartered in London, United Kingdom.
-
What is the size of Metadvice?
Metadvice has 20 total employees.
-
What industry is Metadvice in?
Metadvice’s primary industry is Decision/Risk Analysis.
-
Is Metadvice a private or public company?
Metadvice is a Private company.
-
What is the current valuation of Metadvice?
The current valuation of Metadvice is .
-
What is Metadvice’s current revenue?
The current revenue for Metadvice is .
-
How much funding has Metadvice raised over time?
Metadvice has raised $972K.
-
Who are Metadvice’s investors?
FutureMED VENTURES, King's20 Accelerator, Innovate UK, and Johnson & Johnson Innovation - JLABS have invested in Metadvice.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process